Tinglei Gu

This inventor holds 8 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Bluefin Biomedicine, Inc.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tinglei Gu. Retrieved from https://idiyas.com/inventor/tinglei-gu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

8 out of 17

Bluefin Biomedicine, Inc.

patents

Years Active: 2022-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12491256 - ANTI-CUB DOMAIN-CONTAINING PROTEIN 1 (CDCP1) ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE THEREOF (2025-12-09),

2. 12350347 - Nucleic acids encoding anti-IL1RAP antibodies and their uses (2025-07-08),

3. 12296006 - Anti-LY6H antibodies and antibody drug conjugates (2025-05-13),

4. 12138314 - Anti-CUB domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereof (2024-11-12),

5. 12138313 - Anti-cub domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereof (2024-11-12),

6. 11702481 - Anti-cub domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereof (2023-07-18),

7. 11434303 - Anti-LY6H antibodies and antibody drug conjugates (2022-09-06),

8. 11248054 - Anti-IL1RAP antibodies and antibody drug conjugates (2022-02-15),

Title: Tinglei Gu: Innovator in Antibody Research

Introduction

Tinglei Gu is a prominent inventor based in Andover, MA (US), known for her significant contributions to the field of antibody research. With a total of seven patents to her name, she has made remarkable strides in developing innovative therapeutic solutions.

Latest Patents

Among her latest patents are "Nucleic acids encoding anti-IL1RAP antibodies and their uses," which discloses Interleukin 1 Receptor Accessory Protein (IL1RAP) antibodies and antibody drug conjugates (ADCs). This patent includes compositions and methods for utilizing these antibodies and ADCs effectively. Another notable patent is for "Anti-LY6H antibodies and antibody drug conjugates," which details anti-lymphocyte antigen 6 complex, locus H (LY6H) antibodies and ADCs, along with their compositions and methods of application.

Career Highlights

Tinglei Gu is currently employed at Bluefin Biomedicine, Inc., where she continues to advance her research in antibody development. Her work has been instrumental in creating new therapeutic options for various medical conditions.

Collaborations

Throughout her career, Tinglei has collaborated with esteemed colleagues, including Scott Michael Lonning and Nels Eric Pederson. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Tinglei Gu's contributions to antibody research and her impressive portfolio of patents underscore her role as a leading inventor in the field. Her work continues to pave the way for advancements in medical therapies.

Profile summary based on public USPTO records.